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The worldwide dissemination of metallo-β-lactamases (MBLs), mediating resistance to car-
bapenem antibiotics, is a major public health problem. The extent of dissemination of MBLs
such as VIM-2, SPM-1 and NDM among Gram-negative pathogens cannot be explained
solely based on the associated mobile genetic elements or the resistance phenotype. Here,
we report that MBL host range is determined by the impact of MBL expression on bacterial
fitness. The signal peptide sequence of MBLs dictates their adaptability to each host. In
uncommon hosts, inefficient processing of MBLs leads to accumulation of toxic intermediates
that compromises bacterial growth. This fitness cost explains the exclusion of VIM-2 and
SPM-1 from Escherichia coli and Acinetobacter baumannii, and their confinement to Pseudo-
monas aeruginosa. By contrast, NDMs are expressed without any apparent fitness cost in
different bacteria, and are secreted into outer membrane vesicles. We propose that the
successful dissemination and adaptation of MBLs to different bacterial hosts depend on
protein determinants that enable host adaptability and carbapenem resistance.
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Carbapenems are “last-resort” β-lactam antibiotics
1. Unfor-
tunately, the worldwide spread of carbapenemases (carba-
penem-inactivating enzymes) severely compromises our
therapeutic arsenal to fight life-threatening bacterial infections and
represents a major challenge for public health. Owing to this sce-
nario, the World Health Organization (WHO) has identified
carbapenem-resistant Acinetobacter baumannii, Pseudomonas aer-
uginosa, and Enterobacteriaceae as Priority 1 (“critical”) micro-
organisms for the development of new drugs2. Metallo-β-lactamases
(MBLs) are Zn(II)-dependent enzymes that constitute one of the
major groups of carbapenemases3–6. Despite active research on this
field, inhibitors of MBLs are not commercially available and few
β-lactams are in development that are stable to hydrolysis7,8.
The most relevant MBLs in term of clinical relevance and
geographic dissemination are the families of plasmid-encoded
NDM, VIM, SPM, and IMP. VIM-type enzymes (Verona
integron-encoded MBLs) were first identified in 1996, now
encompassing 60 different allelic variants. VIM-2 is the most
commonly reported MBL worldwide, present in outbreaks in P.
aeruginosa9, being rarely found in Enterobacteriaceae. The São
Paulo MBL (SPM-1) is unique since it is represented by only one
allele that is host-specific10, being confined to P. aeruginosa11.
Instead, the New-Delhi Metallo-β-lactamase (NDM) has been
identified in strains of Enterobacteriaceae, P. aeruginosa, A.
baumannii, and other Gram-negative non-fermenters, showing
the fastest and widest geographical spread among MBLs since its
first identification in 200812,13. These MBLs are present in all
microorganisms labeled as “Priority 1”, but their preferential
distribution into different bacterial hosts is not understood.
Among Gram-negative bacteria, MBLs are synthesized as
cytoplasmic precursors carrying an N-terminal signal sequence
(the signal peptide), which directs them to the secretion
machinery for their translocation into the periplasmic space14,15.
VIM, IMP, and SPM are soluble periplasmic proteins4. In con-
trast, NDM-like β-lactamases are lipoproteins anchored to the
outer membrane in Gram-negative bacteria16–19. This unique
cellular localization favors secretion of NDM variants in outer
membrane vesicles (OMVs)17, as it has been shown in laboratory
strains of E. coli and for blaNDM-1-harboring clinical isolates of
Enterobacter cloacae17. Protein transport by vesicles is advanced
as a mechanism favoring the dissemination of NDM-1, since
NDM-containing vesicles can protect bacteria otherwise suscep-
tible to β-lactams, thus enhancing the communication between
antibiotic-resistant and susceptible bacteria17. This communica-
tion allows for horizontal gene transfer to occur between bacteria
by conjugation, transformation, transduction, or OMV-mediated
gene transfer20,21. Whether this vesicle-mediated protein trans-
port is a general mechanism for all MBLs and for different
organisms is still unknown. On the other hand, bacterial OMVs
can also serve as a pathway to release molecules to alleviate
envelope stress22–24. Thus, we advance the notion that NDM is
secreted into OMVs as a mechanism to relieve the periplasmic
stress caused by membrane insertion of this protein.
Here, we explore the role of the cellular localization, protein
features, and organismal dependence in the secretion of different
MBLs in OMVs from three bacterial species. We discover that
NDM β-lactamases are uniquely tailored to be exported into
OMVs from different Gram-negative pathogens. Instead, VIM-2
and SPM-1 are only secreted into OMVs upon accumulation of
precursor species in non-frequent bacterial hosts, as a response to
the stress caused by these toxic precursors. This phenomenon
accounts for the restriction of these MBLs to Pseudomonas aer-
uginosa, whose fitness is not compromised by expression of these
enzymes. Finally, we identify that the peptide leader sequence of
MBLs is crucial not only in defining their cellular localization, but
also the bacterial host specificity. We propose that the worldwide
dissemination of NDM among different bacterial hosts compared
to other MBLs is not due to the specific genetic environment of
the blaNDM gene neither to its resistance phenotype, but to the
unique and singular features of this protein. NDM β-lactamases
have been shaped during evolution by being able to override the
fitness cost and acquire and maintain resistance determinants in
the absence of evolutionary pressure.
Results
Sorting of MBLs into OMVs is host and protein-dependent. In
order to study the sorting of clinically relevant MBLs in OMVs
secreted by different Gram-negative bacteria, we selected NDM-1,
VIM-2, and SPM-1. These enzymes belong to three representa-
tives of MBLs with different host distribution and prevalence. As
testing organisms, we selected A. baumannii, P. aeruginosa and E.
coli (as representative of Enterobacteriaceae), i.e., the three
pathogens highlighted as “critical” by the WHO2. We expressed
the blaNDM-1, blaVIM-2, and blaSPM-1 genes (each one with its
native signal peptide), under the control of a pTac promoter in
the three different genera of bacteria. The expression level of each
MBL can be modulated by the concentration of added isopropyl-
β-D-thiogalactopyranoside (IPTG). We employed IPTG con-
centrations that induce expression levels similar to those found in
clinical strains17. The three MBLs were expressed fused to a C-
terminal Strep-tag (ST), to allow homogeneous immunodetection
and quantitation both in bacterial cells and in the vesicles. This
tag does not interfere with the proper expression, secretion,
folding, and activity levels of MBLs17.
We measured the minimum inhibitory concentrations (MICs)
of imipenem, ceftazidime, cefepime, and piperacillin, against the
three strains expressing the different MBLs. All were able to confer
resistance to these hosts against all tested antibiotics (Supplemen-
tary Fig. 1 and Supplementary Table 1). Specifically, NDM-1
conferred the highest resistance levels in P. aeruginosa and A.
baumannii, while SPM-1 had the best performance among the
three proteins in E. coli. The observed phenotypes do not correlate
with the host preferences of VIM-2 and SPM-1. Socha et al.25 have
recently shown that the phenotypic variation in resistance among
MBLs in different organisms is explained from a combination of
the catalytic efficiency and abundance of functional periplasmic
enzyme, in line with previous published observations26.
Figure 1a (top panel) shows the protein levels of the three
MBLs expressed in E. coli, P. aeruginosa and A. baumannii,
detected in whole cells. In the case of NDM-1, only the mature
protein was detected in the three strains, displaying lower
expression levels in A. baumannii compared to E. coli or P.
aeruginosa. Instead, VIM-2 and SPM-1 showed accumulation of
both the precursor (indicated in red arrows, Fig. 1a) and the
mature forms when these proteins were expressed in E. coli. Cell
fractionation and proteinase K treatment of E. coli spheroplasts
showed that the precursor forms of VIM-2 and SPM-1 are
associated with the periplasmic face of the inner membrane as
part of insoluble aggregates (Fig. 1b and Supplementary Fig. 2). In
the case of A. baumannii, we observed that the synthesis of VIM-
2 is highly compromised, detecting only the mature form in low
levels. However, at longer times of induction (stationary phase),
we detected higher levels of VIM-2 in both precursor and mature
forms (Supplementary Fig. 3). On the contrary, the protein levels
of SPM-1 expressed from A. baumannii cells were high, showing
the accumulation of mature and precursor forms. Instead,
accumulation of the precursor was not observed in P. aeruginosa
strains expressing VIM-2 or SPM-1, where only the mature forms
of these enzymes were detected (Fig. 1a, top panel).
We purified OMVs secreted from these bacteria, expressing
NDM-1, VIM-2, or SPM-1. Transmission electron microscopy
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(Supplementary Fig. 4a and Supplementary Fig. 4b) showed the
presence of homogeneous and spherical vesicles (diameters
ranging from 20 to 120 nm) free of contaminants, such as fimbriae
and flagella. Sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) demonstrated that MBL expression does not
affect the overall protein profiles in OMVs, regardless the MBL
cargo (Supplementary Fig. 5). Moreover, these MBLs represent a
minor portion of the total protein content of vesicles (Supple-
mentary Fig. 5). NDM-1 levels in OMVs from all three strains were
similar (Fig. 1a, bottom panel). Instead, VIM-2 and SPM-1 were
found in vesicles from E. coli and A. baumannii, while traces of
these proteins were not found in OMVs purified from P.
aeruginosa cells expressing these MBLs (Fig. 1a, bottom panel).
We next measured carbapenemase activity in vesicles from all
organisms using imipenem as a substrate (Fig. 1c), revealing that
the OMVs contain folded and metal-loaded MBLs. However, we
stress that the measured activities do not always correlate with the
protein levels in vesicles (Fig. 1a, bottom panel).
These observations indicate that MBL secretion into OMVs
depends on the properties and characteristics of the protein and
the bacterial host. The case of NDM-1 is unique, being secreted as
a folded and active protein into OMVs in the three studied
organisms that serve as NDM-1 hosts. In contrast, VIM-2 and
SPM-1 are not present in vesicles produced by P. aeruginosa, the
frequent host of these MBLs in clinical isolates, while secretion of
these two MBLs into vesicles in E. coli and A. baumannii
correlates with an accumulation of the precursor protein.
Expression of MBLs in non-frequent hosts compromises fit-
ness. The production of OMVs was increased (up to 7-fold) in E.
coli- and A. baumannii-expressing VIM-2 or SPM-1 with respect
to control cells transformed with the empty vector (see Fig. 2a).
This hypervesiculation phenotype was not observed in P. aeru-
ginosa cells expressing VIM-2 or SPM-1 (Fig. 2a). In the case of
NDM-1, similar levels of vesicles were produced in all tested
organisms, indicating that expression of NDM-1 does not affect
OMV production in these bacteria. This correlates with the
finding of NDM-1 in vesicles from all three organisms (Fig. 1a).
A hypervesiculation phenotype is frequently associated with an
envelope cell stress response, where OMV production acts as a
mechanism to alleviate conditions that compromise bacterial
fitness23,27. We reasoned that expression of VIM-2 and SPM-1
may generate an envelope stress in E. coli and A. baumannii. We
tested this hypothesis by evaluating the impact of MBLs
expression on bacterial growth, as a measurement of bacterial
fitness. The growth curves of E. coli, P. aeruginosa and A.
baumannii expressing the different MBLs in the absence of
selective pressure show strikingly different profiles (Fig. 2b and
Supplementary Fig. 6). The expression of blaNDM-1 does not entail
a fitness cost in any of the three strains assayed, even at high
levels of IPTG added to induce protein expression (Fig. 2b and
Supplementary Fig. 6). Instead, expression of VIM-2 or SPM-1
causes a dramatic effect in the fitness of E. coli and A. baumannii,
severely compromising the bacterial growth rates (Fig. 2b). In the
case of A. baumannii, expression of VIM-2 provokes a stronger
growth defect compared to SPM-1, which is evidenced by a
prolonged lag period. This compromised cell metabolism would
explain the lower synthesis of VIM-2 observed at this stage of
growth, as mentioned above (Fig. 1a, top panel).
Larger concentrations of IPTG induce higher expression levels
of VIM-2 and SPM-1 that further retard the growth of E. coli and




























































Fig. 1MBL sorting in OMVs from E. coli, P. aeruginosa and A. baumannii. a NDM-1, VIM-2, and SPM-1 levels (fused to a C-terminal Strep-tag sequence, -ST)
by immunoblotting, using anti-Strep-tag antibodies, in whole cells (WC, top panel) and in OMVs purified from the corresponding cell culture supernatants
(OMVs, bottom panel) from E. coli DH5α [Ec], P. aeruginosa PAO1 [Pa] and A. baumannii ATCC 17978 [Ab] strains expressing each MBL, after induction
with 20 µM IPTG. Gel lanes were loaded with equal amounts of total protein. Red arrows indicate the precursor forms in whole cells from E. coli-expressing
VIM-2 or SPM-1 and from A. baumannii-expressing SPM-1. The presence of cytoplasmic contaminants in vesicle preparations was assessed by immunoblot
of GroEL. b Immunoblot of spheroplasts from E. coli-expressing VIM-2 or SPM-1 treated with (+ K) or without (-K) Proteinase K to asses accessibility of
precursor forms. Panels a and b are representative of two independent experiments. c Imipenem hydrolysis rate by OMVs purified from E. coli, P.
aeruginosa, and A. baumannii cells expressing NDM-1, VIM-2, and SPM-1. Data correspond to three independent experiments and are shown as the mean
value. Error bars represent standard deviations (s.d). Source data are provided as a Source Data file
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expression of VIM-2 or SPM-1 was lethal at 50 µM IPTG
(Supplementary Fig. 6). The expression of SPM-1 in E. coli strains
at 50 µM of IPTG also resulted in cell death (Fig. 2b, right top
panel). In stark contrast, P. aeruginosa strains expressing VIM-2
or SPM-1 showed normal growth curves (Fig. 2b and Supple-
mentary Fig. 6). This correlates with the observation that P.
aeruginosa cells do not elicit secretion of VIM-2 or SPM-1 into
OMVs (Fig. 1a). These results unveil a positive correlation
between the accumulation of precursor forms of VIM-2 and
SPM-1, the biological cost upon expression of these enzymes and
their secretion into vesicles in E. coli and A. baumannii.
We conclude that VIM-2 and SPM-1 are not readily secreted in
OMVs from their most frequent host (P. aeruginosa), since their
expression does not compromise bacterial fitness. Instead, we
observed that the expression of NDM-1 does not affect the
growth of any of three bacteria tested and, moreover, is packaged
in OMVs produced by all studied organisms. The differential
behavior is more evident in P. aeruginosa strains, since their
OMVs contain NDM-1 and not VIM-2 or SPM-1, despite the two
latter MBLs are isolated with high frequency in this bacterium.
Altogether, our results indicate that the preferential inclusion of
NDM-1 in the vesicles of different microbial hosts depends on
mechanisms of selective sorting associated with unique features of
NDM-1, instead of being specific host issues. Moreover, we can
discard the notion that NDM are eliminated into vesicles to
relieve the cell from periplasmic stress. Instead, the selective
secretion of VIM-2 and SPM-1 into vesicles in non-frequent
hosts, associated with a hypervesiculation phenotype, discloses
the presence of envelope stress in these cases.
Expression of MBLs in non-frequent hosts induces envelope
stress. In order to understand how MBL expression induces
vesicle production in non-frequent hosts, we attempted to iden-
tify the molecular mechanisms involved in this phenomenon. A
hypervesiculation phenotype can be triggered by different inde-
pendent mechanisms28. We decided to focus on the two most
probable pathways, which includes: (a) decrease in the covalent
OM-peptidoglycan cross-linking that favors OM bulging, or (b)
the accumulation of toxic species in the bacterial envelope that
are eliminated in the OMV27. We selected E. coli as a model
system to study this phenomenon.
The first mechanism can be interrogated by measuring the
levels of Lpp, the most abundant lipoprotein responsible for
tethering the outer membrane (OM) to the peptidoglycan
sacculus27,29,30. We purified sacculi isolated from E. coli DH5α
strains expressing SPM-1 or VIM-2. HPLC analysis of these
sacculi revealed that levels of lipoprotein (Lpp)-linked muropep-
tides were unaltered in both cases compared to a control E. coli
strain not expressing MBLs (Supplementary Table 2). These
results allowed us to discard this hypothesis.
The accumulation of toxic proteins in the periplasm can be
evidenced by an increase in the levels and/or activity of DegP, the
central housekeeping protein in the bacterial envelope that
eliminates toxic species22,31–33. In fact, DegP and OMV
production act in concert to alleviate this type of periplasmic
stress27,34. We observed that DegP levels were increased 1.4- and
1.7-fold more in E. coli cells expressing VIM-2 or SPM-1,
respectively, than E. coli cells harboring the empty vector. This
finding is accompanied with a notable accumulation of short-
DegP35, an autoproteolysis product of DegP, revealing that DegP
is activated to relieve envelope stress35 (Fig. 3a). Instead, E. coli
cells expressing NDM-1 do not show significant changes in DegP
levels as evidence of degradation products could not be found
(Fig. 3a).
The impact of the activity of DegP activity upon expression of
VIM-2 or SPM-1 was tested by comparing the growth curves of
the wild-type E. coli strain and the ΔdegP mutant (Fig. 3b), both
expressing different MBLs. The ΔdegP strain was able to grow at
similar rates than the wild-type strain in the presence of an empty
vector or when expressing the non-toxic NDM-1. Instead,
expression of either VIM-2 or SPM-1 was lethal to knockout
degP cells. Taken together, these results indicate that E. coli
experiences a severe periplasmic stress upon expression of the
non-host-adapted proteins, VIM-2 or SPM-1. This stress can be
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Fig. 2 Expression of VIM-2 and SPM-1 in non-frequent hosts induces
hypervesiculation and compromises fitness. a Relative fold OMV
production in cultures of the indicated hosts (Ec, Pa, or Ab) expressing
blaNDM-1, blaVIM-2, or blaSPM-1 at 20 µM of IPTG. OMVs were quantitated
based on total protein concentrations, normalizing to OD600, and dividing
by OD600-normalized OMV production in control samples (corresponding
to cells harboring the empty vector). Data correspond to three independent
experiments and are shown as the mean value. Error bars represent
standard deviations (s.d). b Growth curves for E. coli, A. baumannii, and P.
aeruginosa carrying the empty vector (Vector) or expressing blaNDM-1,
blaVIM-2, or blaSPM-1 in aerobic conditions in LB medium at 37 °C with 20 µM
of IPTG. OD600 of the cultures was recorded every hour for 15 h. Data
correspond to three independent experiments and are shown as the mean
value. Error bars represent standard deviations (s.d). Right top panel:
bacterial viability in a spot plating assay. Overnight cultures from E. coli
expressing the different MBLs were serially diluted and 10 µl aliquots
spotted onto LB agar without (-) or with the addition of 50 µM of IPTG.
Colonies were allowed to develop for 24 h at 37 °C. Source data are
provided as a Source Data file
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vesicle-mediated elimination of the toxic MBLs that is reflected in
the hypervesiculation phenotype.
The signal peptide of MBLs determines bacterial fitness. We
sought to identify the molecular features by which expression of
blaVIM-2 or blaSPM-1 compromise bacterial fitness in E. coli. In
principle, this could be due to: (1) the enzymatic activity of the
MBLs, (2) their cellular localization, or (3) the distinctive mole-
cular features of each MBL. Firstly, we examined whether the
carbapenemase activity was responsible of conferring the
observed growth defects. Addition of a specific MBL inhibitor
(bisthiazolidine compound: L-CS31936) to E. coli cells expressing
VIM-2 or SPM-1 did not alleviate the MBL-mediated toxicity
(Supplementary Fig. 7), allowing us to conclude that the activity
of MBLs is not responsible for the microbial fitness upon
expression.
Since NDM-1 is membrane-bound and VIM-2 is a soluble β
lactamase, we explored the possible role of the cellular
localization of MBLs on the toxicity to the host cell. Membrane
anchoring in NDM-1 is coded in a lipidation sequence (lipobox)
in the signal peptide. We previously determined that the cellular
localization of NDM-1 and VIM-2 can be altered by swapping the
signal peptides of these proteins17. V2-NDM-1 is a chimera of
mature NDM-1 and the N-terminus of the VIM-2, that is a
soluble periplasmic protein; and N1-VIM-2 is a chimeric protein
in which the sequence of mature VIM-2 is preceded by the N-
terminal signal peptide of NDM-1, resulting in a membrane-
anchored form of VIM-2 (Fig. 4a). The soluble variant V2-NDM-
1 induced severe growth defects in E. coli cells, in contrast to
membrane-bound NDM-1 and resembling the behavior of VIM-2
(Fig. 4b, top panel). On the other hand, membrane-anchored
VIM-2, N1-VIM-2 did not elicit any growth defect (Fig. 4b,
medium panel). These results could in principle suggest that
membrane anchoring would prevent MBLs from being toxic in E.
coli. MBLs with a lipobox can also be expressed as soluble
proteins by mutating the Cys residue in the lipidation site
(mutant C26A)17. Surprisingly, none of the soluble variants
NDM-1C26A and N1C26A-VIM-2 compromised the bacterial
growth, disproving the previous hypothesis (Fig. 4b, top and
medium panel). These findings suggest that the identity of the
signal peptide governs the impact of MBL expression on bacterial
fitness. Indeed, immunoblot analysis of E. coli cells expressing
these variants shows clearly that those chimeras with the VIM-2
signal peptide present accumulation of the precursor form
(Fig. 4b, bottom panel). In conclusion, while the cellular
localization has an impact on the bacterial fitness of MBLs
expression, the N-terminus of VIM-2 seems to be the main
determinant of the impact of MBL expression on bacterial fitness
and toxicity. Phylogenetic analysis of signal peptide sequences did
not cluster according to MBLs’ host range, indicating non-
obvious sequence determinants defining the distribution of these
enzymes among bacterial species (Supplementary Fig. 8).
We next decided to test the role of the information contained
in the signal peptide sequence on bacterial fitness, by studying
different soluble MBLs. We selected the soluble enzymes VIM-2,
VIM-1, and IMP-1. The two natural VIM variants, VIM-2 and
VIM-1 differ only by 17 residues37–39, seven of them being
located in the signal peptide. IMP-1, instead, belongs to a
different family of clinically relevant, soluble MBLs, divergent in
sequence respect to the VIM family39,40. All three proteins are
expressed to similar levels in E. coli cells. However, cells
expressing VIM-1 show a minor reduction in the growth curves
(Fig. 4c, d and Supplementary Fig. 9) despite the close homology
with VIM-2. Expression of IMP-1 gives rise to growth curves
similar to cells carrying the empty vector, a fact that discloses the
absence of fitness cost upon expression of this MBL (Fig. 4c, d
and Supplementary Fig. 9).
To validate our hypothesis, we constructed a new set of
chimeric enzymes by swapping the signal sequences of VIM-2
and VIM-1, and VIM-2 and IMP-1, and we measured the growth
curves of E. coli cells expressing these variants. Substitution of the
signal peptide of VIM-2 by those of VIM-1 or IMP-1 (variants
V1-VIM-2 and I1-VIM-2) alleviated the fitness cost caused by
expression of wild-type VIM-2 (see Fig. 4c, d). Conversely,
expression of IMP-1 using the signal sequence of VIM-2 (V2-
IMP-1) yielded few and very small colonies, indicating that
production of this variant is defective. Indeed, expression of this
variant elicited strong growth defects even when cells were grown
without adding IPTG (Fig. 4c, d). The only exception is
expression of VIM-1 with the peptide leader of VIM-2, which
does not compromise bacterial fitness (Fig. 4c, d). Finally, all
cases of cells with growth defects expressing these variants
showed accumulation of the precursor forms (Fig. 4c, bottom
panel). We conclude that the signal peptide of VIM-2 is
responsible of eliciting envelope stress in E. coli by accumulation
of the precursor protein that is toxic to the cell and compromises
bacterial fitness.
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Fig. 3 Expression of VIM-2 and SPM-1 in non-frequent hosts induces
envelope stress. a DegP-3xFLAG protein levels by western blot, using anti-
FLAG antibodies, in whole cells from degP-3xFLAG E. coli cells carrying the
empty vector or expressing each MBL, at 20 µM of IPTG. Short- DegP is
showed in cells expressing blaVIM-2 or blaSPM-1. This form of DegP indicates
that mature DegP was self-cleaved in vivo. GroEL was used as a load
control. This panel is representative of two independent experiments.
b Growth curves of the degP null (ΔdegP) and wild-type E. coli strains,
carrying the empty vector (Vector) or expressing blaNDM-1, blaVIM-2, or
blaSPM-1 in aerobic conditions in LB medium at 37 °C with 20 µM of IPTG.
The growth was monitored as above. Data correspond to three independent
experiments and are shown as the mean value. Error bars represent
standard deviations (s.d). Source data are provided as a Source Data file
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Fig. 4 Impact of cellular localization and protein features of the MBLs on fitness cost. a Schematic representation of the chimeric MBLs variants with altered
cellular localizations and engineered signal peptides. NT: N-terminus and CT: C-terminus. OM: protein lipidated and anchored to outer membrane. S: soluble
periplasmic protein. C: cysteine anchoring residue into lipobox sequence. A: alanine residue. By mutation of the cysteine residue by an alanine residue,
C26A, the lipidation site is removed resulting in a soluble variant. The same color coding is used for each variant throughout this Figure. b Growth curves of
E.coli strains expressing blaNDM-1 or blaVIM-2 with altered cellular localizations in LB at 37 °C with 50 µM of IPTG (top and medium panels). The growth was
monitored as above. Data represent the mean value (±s.d) of three independent experiments. Bottom panel: Protein levels of NDM-1, VIM-2 and their
chimeras with altered cellular localizations by immunoblotting in whole cells from E. coli expressing each MBL after induction at 20 µM with IPTG. Red
arrows indicate the precursor forms. c Growth curves of E. coli strains expressing blaIMP-1, blaVIM-2, and their chimeras with their exchanged signal
peptidesI1-VIM-2 and V2-IMP-1 (top panel). Growth curves of E. coli strains expressing blaVIM-1, blaVIM-2, and their chimeras with their exchanged signal
peptides (medium panel). Bottom panel shows the protein levels of VIM-2, VIM-1, and their chimeras with their signal peptides swapped, by immunoblot
analysis. Lower panels show loading control (GroEL). d Bacterial viability in a spot plating assay. Overnight cultures from E. coli expressing VIM-2, IMP-1,
VIM-1, and their chimeras were serially diluted and 10 µl aliquots spotted onto LB agar without (−) or with the addition of 50 µM of IPTG (+). Colonies
were allowed to develop for 24 h at 37 °C. Panels c (bottom panel) and d are representative of two independent experiments. Source data are provided as a
Source Data file
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11615-w
6 NATURE COMMUNICATIONS |         (2019) 10:3617 | https://doi.org/10.1038/s41467-019-11615-w | www.nature.com/naturecommunications
Discussion
Gram-negative pathogens expressing MBLs seriously threaten
public health. Plasmid-encoded MBLs are disseminating world-
wide at an alarming pace among these pathogens, conferring
resistance to carbapenems and limiting the usefulness of these
last-resort antibiotics. Many elegant studies have shown a strong
relationship between the rapid spread of MBL genes and the
presence of conjugative plasmids41–44. However, the rapid spread
of the blaNDM-1 gene in a short period of time in multiple bac-
terial hosts could not solely be attributed to the genetic platform
harboring this gene. Despite K. pneumoniae and E. coli are the
most frequently described NDM-1-producing bacteria45,46, the
blaNDM-1 gene has also been found in non-fermentative bacteria
including P. aeruginosa and Acinetobacter spp.47, and in a
number of environmental organisms, such as Enterobacter
asburiae, Providencia rettgeri, and Acinetobacter baylyi. In con-
trast, the host preferences of VIM alleles are very diverse. VIM-2,
the most prevalent MBL, despite being present in plasmids of
broad host range48, has been mostly detected in P. aeruginosa
isolates9,49. There are exceptional reports of Enterobacteriaceae
members, such as E. coli and Serratia marcescens, producing
VIM-250,51. These particular strains, however, may have co-
evolved to endure the toxicity associated with VIM-2 expres-
sion52. The variant VIM-1 (differing by only 17 residues with
VIM-2), instead, is more frequently isolated in Enterobacteriaceae
(such as E. coli ST 131) and non-fermenters9,53,54. Finally, SPM-1
is exclusively confined to P. aeruginosa9. Surprisingly, the resis-
tance phenotype of NDM-1, VIM-2 and SPM-1 in different hosts
does not correlate with these host preferences, and little is known
about the mechanisms that determine this puzzling host
specificity.
In the present study, we report how the molecular features of
MBL proteins elicit different fitness costs when expressed in
bacteria under permissive conditions (i.e., in the absence of the
evolutionary pressure of antibiotics). We identify this fitness cost
as a selection driver that determines the dissemination of MBLs
and their host specificity. This fundamental property does not
only apply to differentiate distinct MBL families, since subtle
changes such as few mutations among allelic variants elicit drastic
effects in fitness cost upon MBL expression, impacting on host
specificity. Based on this paradigm, we show that NDM-1 is
uniquely tailored to be expressed without inducing any fitness
cost in different bacterial hosts, in contrast to other MBLs.
The soluble lactamases VIM-2 and SPM-1, instead, induce a
high fitness cost by compromising bacterial growth when
expressed in A. baumannii and E. coli, which are not frequent
hosts for these MBLs. VIM-2 and SPM-1 are capable of con-
ferring resistance to β-lactam in non-frequent hosts, being able to
outperform their resistance profile in P. aeruginosa in some cases
(Fig. S1 and Table S1). Thus, host specificity cannot be explained
only based in the resistance phenotype of MBLs in different hosts.
Previous studies have shown that the fitness cost under permis-
sive conditions compromises the persistence of an antibiotic
resistance determinant in a specific bacterial host55–57. In the
particular case of the carbapenemase SME-1, Marciano et al.55
have shown that mutations in its signal peptide alter the fitness
cost of protein expression. Our results show that this effect has
been dominant in the distribution and host specificity of MBLs.
Reduction of the bacterial growth is accompanied in all cases
by accumulation of the precursor protein in non-frequent or less
common hosts. Instead, expression of either VIM-2 or SPM-1 in
their frequent host P. aeruginosa, does not imply any burden, an
observation that is associated with the absence of accumulation of
the precursor protein. We demonstrate that accumulation of
precursor MBLs entails an envelope stress. This conclusion is
supported by the finding of growth defects, a hypervesiculation
phenotype and a periplasmic stress response, as evidenced by the
activation of the housekeeping protease DegP. We hypothesized
that accumulation of the toxic precursor forms could be due to
the sequence of the signal peptides, which may lead to deficient
translocation and processing events in some hosts. We demon-
strate that this is the case by engineering chimeric proteins that
allowed the expression of several MBLs with other signal pep-
tides. Expression of VIM-2 with the signal peptide of other
soluble MBLs (such as VIM-1 or IMP-1) minimizes or even
abolishes the growth defects observed when expressing this MBL
in E. coli and A. baumannii, revealing that these leader peptides
are more efficiently processed by the protein export machinery in
these hosts. Expression of VIM-1 in E. coli and A. baumannii
impaired bacterial growth to a minor extent, unlike expression of
VIM-2, which can be lethal. These results demonstrate that the
signal peptide sequence is a main determinant of the toxicity of a
given MBL in different bacterial hosts.
Most VIM alleles can be classified into two groups deriving
from VIM-1 and VIM-2. The host prevalence reported for the
different blaVIM genes resembles those of the parent gene, con-
firming this hypothesis. VIM-12 is a particular case, being a VIM-
1/VIM-2 hybrid that results from the N-terminal sequence from
VIM-1 (including the signal peptide) and the C-terminus from
VIM-258. Despite being present in genetic cassettes similar to
those of VIM-2, the blaVIM-12 gene has been reported only in
Enterobacteriaceae58, revealing that the signal peptide is more
important than the genetic environment of the MBL gene in
determining the host specificity. Moreover, this sequence can be
used to predict the host specificity and possible spread of new
MBL alleles.
Type I signal peptidases (SPase I) are responsible of cleaving
the signal peptides from the secretory precursor proteins during
translocation across the cytoplasmic membrane59–61. Most
Gram-negative bacteria possess a single SPase I62, while Pseudo-
monas aeruginosa is an exception in expressing two signal pep-
tidases63. It would be interesting to assess in future work whether
incorporation of an additional SPase I, or an increase in endo-
genous SPase I levels may help to alleviate the stress caused by
accumulation of toxic precursors. In any case, the saturation of
the protein export machinery to the cell envelope is responsible
for the fitness cost triggered upon expression of these enzymes.
Processing of NDM-like enzymes follows a different pathway.
NDM β-lactamases are lipoproteins anchored to the outer
membrane, and their posttranslational processing requires the
action of signal peptidase II (SPase II) that recognizes the lipobox
sequence and cleaves the signal peptide16,64. Since membrane
anchoring provides several evolutionary advantages to NDM-1,
we tested whether its cellular localization could be responsible of
the lack of fitness cost imposed by expression of this enzyme.
However, expression of the soluble variant NDM-1 C26A was not
toxic to E.coli cells, allowing us to discard the notion that
membrane anchoring could be responsible of the adaptability of
NDM to different hosts. Instead, expression of NDM-1 with the
leader peptide of VIM-2 lead to precursor accumulation and
associated growth defects. Overall, these results highlight the
crucial role of the signal peptide in defining the adaptability of
different MBLs to particular bacterial hosts.
Production of OMVs is a mechanism that helps alleviating
envelope stress by eliminating toxic proteins from the periplasm
of Gram-negative bacteria. This is the case for VIM-2 and SPM-1
in non-frequent hosts, such as E. coli and A. baumannii. Our
assertion is supported by the finding that these proteins are not
packaged into OMVs from its most frequent host, P. aeruginosa.
NDM-containing vesicles show higher specific activity than
OMVs carrying VIM-2 or SPM-1 (Supplementary Fig. 4c). Since
MBLs are active when they are properly folded and loaded with
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Zn(II), we conclude that a fraction of VIM-2 and SPM-1 secreted
into vesicles is not properly folded. Indeed, the lower specific
activity of SPM-1 into E. coli and A. baumannii vesicles indicate a
larger accumulation of misfolded protein, in line with the more
restricted host specificity of this MBL compared to VIM-2. These
results are in line with the observation that the accumulation of
toxic misfolded porins in the periplasm of E. coli induces envel-
ope stress that is partially relieved by secretion of these misfolded
proteins in OMVs34.
NDM-1 is exported to vesicles in E. coli, P. aeruginosa and A.
baumannii, a process that cannot be correlated to any envelope
stress caused by protein expression. Indeed, expression of NDM-1
as a membrane-bound protein did not compromise bacterial
growth in any of the bacteria tested here, and exhibited adequate
posttranslational processing. We conclude that expression of
NDM-1 is favored in many microorganisms due to the lack of
fitness cost, accounting for the broad host range of this MBL.
These results also reveal that NDM-1 is tailored to be selectively
secreted into OMVs. NDM-1-containing vesicles showed a high
carbapenemase activity, i.e., NDM-1 is secreted as a folded and
active protein. This selective secretion of NDM-1 β-lactamase
into vesicles may then serve another purpose.
Secretion of NDM-1 into vesicles has been proposed as a
mechanism that may help disseminating the blaNDM gene17. This
secretion implies an advantage to the organism under the pre-
sence of antibiotics by disseminating the carbapenemase activity
beyond the bacterial cell17, thus titrating the available antibiotic at
the infection site. At the same time, these vesicles are able to
protect populations of otherwise susceptible bacteria, favoring the
opportunity of uptaking the blaNDM gene by horizontal gene
transfer or by the OMVs themselves21. This could be crucial in
polymicrobial infections, resulting in lethal treatment failure. The
current results strongly support the role of OMVs in the dis-
semination of NDM-1. This enzyme clearly exhibits many evo-
lutionary advantages attributable to its protein features compared
to other clinically relevant MBLs, such as VIM-2 and SPM-1.
Since the signal peptide is highly conserved in all NDM alleles, we
anticipate that these features are preserved in all proteins from
the NDM family.
Bacteria use a toolkit for acquiring, maintaining and dis-
seminating resistance that involves different features and has been
shaped by evolution. On one hand, the intrinsic features of the
genetic mobile elements coding for resistance genes impact on the
rate of dissemination of the bla genes. On the other hand, the β-
lactamase activity of the different proteins acts as a selection
driver of certain alleles that are better adapted to some hosts
under the evolutionary pressure of specific β-lactams. This is the
case of SPM-1, whose active site is finely tailored by unique
mutations to hydrolyze anti-pseudomonal antibiotics, thus being
an enzyme restricted to P. aeruginosa strains10. Also, the cefta-
zidimase activity of VIM proteins has been shown to be a
selection driver of this family of MBLs65. In addition to these
well-known mechanisms, here we provide compelling evidence
that the signal peptide is a key protein determinant in MBLs that
defines the host adaptability in the absence of antibiotics based on
the fitness cost resulting from its expression.
Antibiotic resistance affects bacterial fitness under permissive
conditions. This fitness cost compromises the chances of
acquiring and maintaining genes able to confer resistance under
more stringent conditions. Thus, bacteria must deal with a
balance between the gain of function, that is relevant for sur-
vival to face the challenge of antibiotics, and the loss of function
upon the deleterious effect of MBL production in the absence of
antibiotic selective pressure. We propose that the lack of fitness
cost of expressing NDM-1 and its secretion into OMVs are two
selection drivers that have favored the worldwide and broad
host range dissemination of this β-lactamase, boosting the
impact of its resistance phenotype. This paradigm allows us to
account for the epidemiology of the different MBLs. Knowledge
of the biological cost of expressing MBLs is of relevance not
only to anticipate resistance dissemination among different
hosts, but also to evaluate clinical interventions that may help
in reducing resistance.
Methods
Bacterial strains and growth conditions. The representative species for this study
were the following strains: Acinetobacter baumannii ATCC 17978 [Ab], Pseudo-
monas aeruginosa PAO1 [Pa] (both representatives of non-fermenter organisms)
and Escherichia coli DH5α [Ec] (as representative of Enterobacteriaceae). For each
organism studied, a set of isogenic clones expressing different wild-type MBL genes
(blaNDM-1, blaVIM-2, blaSPM-1, blaIMP-1, and blaVIM-1) and chimeras (blaNDM-1C26A,
blaV2-NDM-1, blaN1-VIM-2, blaN1C26A-VIM-2, blaI1-VIM-2, blaV2-IMP-1, blaV1-VIM-2, and
blaV2-VIM-1) was constructed. E. coli DH5α and P. aeruginosa PAO1 were used for
expression of empty vector pMBLe and also for expression of the different MBLs
already cloned in the pMBLe17. A. baumannii ATCC 17978 was used for expres-
sion of plasmids pMBLe-OA and pMBLe-OA-blaMBLs, constructed in this work as
explained below. Cells were routinely grown aerobically at 37 °C in Luria–Bertani
(LB broth) or on LB agar plates, except when indicated. Gentamicin was used when
necessary at 20 µg ml−1. All reagents and chemicals were from Sigma-Aldrich,
except the LB culture media that were from Difco, and oligonucleotides and
enzymes that were from Life Technologies.
Plasmid and strain construction. Plasmid isolation, DNA purification, restriction
enzyme digestion, ligation, and transformation were performed by standard
methods according to Sambrook et al.66. For expressing the different bla genes
either in E. coli or P. aeruginosa, constructions of the MBL variants already cloned
in the pMBLe17 were used, which contain the full-length blaMBLs genes, including
their native signal peptides, fused to a C-terminal Strep-tag II sequence under the
control of an β-IPTG-inducible pTac promoter. To clone and express blaVIM-1, the
same strategy was used as for the other MBLs17. Briefly, the full-length blaVIM-1
gene was PCR-amplified from a genomic preparation of clinical isolate producing
VIM-1 (E. coli M13488), kindly provided by Dr. Roberto Melano (Public Health
Ontario Lab, Canada), using primers VIM1NdeIFw (5ʹ-GACATCATATGTTAAA
AGTTATTAGTAGTTTATTGGTC-3′) and VIM1StHindIIIRv (5′-GACGTAAGC
TTCTACTTTTCGAATTGTGGGTGAGACCACTCGGCGACTGAGCGATTTT
TGTG-3′)
The pMBLe plasmid can efficiently replicate in E. coli and P. aeruginosa17, but
did not in A. baumannii. For this, the pMBLe was modified by cloning 1337 bp ori
region from pWH1266 into AgeI restriction site of pMBLe using primers
oriAbAgeIFw (5′- ATATACCGGTGATCGTAGAAATATCTA-3′) and
oriAbAgeIRv (5′-ATATACCGGTGGATTTTAACATTTTGC-3′), obtaining the
pMBLe-OA plasmid, replicative in A. baumannii. The pWH1266, an Acinetobacter
genus specific plasmid67, and A. baumannii ATCC 17978 strains were kindly
provided by Dra. Alejandra Mussi (CEFOBI-CONICET, Argentina). Through
subcloning by restriction enzyme digest, using BamHI and HindIII, except in the
case of blaIMP-1, in which it was used BamHI and EcoRI, we subcloned each blaMBL
gene in the pMBLe-OA.MBL expression was induced with low concentrations of
IPTG (10–50 μM), as indicated.
The construction of the degP-3xFLAG KmR strain was performed as described68.
Briefly, E. coli DH5α containing plasmid pKD4669 was transformed with a PCR
product generated using primers degP-3xFLAGFw (5′-CATTCAGCGCGGCGAC
AGCACCATCTACCTGTTAATGCAGGACTACAAAGACCATGACGG-3′) and
degP-3xFLAGRv (5′-GGAGAACCCCTTCCCGTTTTCAGGAAGGGGTTGAGGG
AGACATATGAATATCCTCCTTA-3′) and plasmid pSUB11 as template68. Once
obtained, E. coli cells carrying the chromosomal degP-3xFLAG allele were
transformed with the empty vector or the vector harboring each blaMBL. To
determine the intracellular levels of the DegP protein in cells expressing the different
MBLs, western blot analyses were performed as described previously17, with mouse
anti-FLAG monoclonal antibodies (clone M2, Sigma-Aldrich) and immunoglobulin
G-alkaline phosphatase conjugates (at a 1:3000 dilution). Protein band intensities
were quantified from polyvinylidene difluoride (PVDF) membranes with ImageJ
software70. Uncropped images of the western blot are provided in the Source Data
file. The PageRuler Plus Prestained Protein Ladder (Thermo Scientific #26616)
provided molecular weight standards for Figs. 1a and 3a. The Precision Plus Protein
Standards Kaleidoscope (BioRad #161–0375) provided molecular weight standards
for Figs. 1b and 4c, as shown in the Source Data file.
The strain ΔdegP carrying gene deletion in degP, derivative of E. coli DH5α, was
generated by Lambda Red-mediated recombination using previously protocols69
and the primers degP-P1 (5′-ACAGCAATTTTGCGTTATCTGTTAATCGAGA
CTGAAATACgtgtaggctggagctgcttcg-3′) and degP-P2 (5′-GGAGAACCCCTTCCC
GTTTTCAGGAAGGGGTTGAGGGAGAcatatgaatatcctcctta-3′).
Construction of MBL mutants. The different MBLs variants with their signal
peptides swapped (I1-VIM-2, V2-IMP-1, VIM-V1-VIM-2, and V2-VIM-1)
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TAGCCATGATAG-3′) with external primers pMBLeFw (GCTGTTGACAATTA
ATCATCGGTC) and pMBLeRv (CACTACCATCGGCGCTACG); employing the
same strategy previously used by us for the generation of the NDM-1 or VIM-2
variants with altered cellular localizations17. The PCR-amplified genes were sub-
cloned into plasmid pMBLe in E. coli strains. All constructs were verified by DNA
sequencing (University of Maine, USA).
MBL detection and β-lactamase activity measurements. MBL protein levels
were determined by SDS-PAGE followed by western blotting with Strep-tag II
monoclonal antibodies (at a 1:1000 dilution from 200 μg ml−1 solution) (Novagen)
and immunoglobulin G-alkaline phosphatase conjugates (at a 1:3000 dilution).
Briefly, the samples were mixed with loading buffer and heated to denature the
peptide structure. SDS-PAGE (14%) was used for separation of the sample com-
ponents and subsequently transferred onto a PVDF membrane (GE). Western
blotting with antibodies detecting GroEL was performed as a loading control. β-
lactamase activity was measured in a JASCO V-670 spectrophotometer at 30 °C in
10mM HEPES, 200mM NaCl pH 7.4 (for OMVs), in 0.1 cm cuvettes, using 400 μM
imipenem as a substrate. Imipenem hydrolysis was monitored at 300 nm (Δε300nm
=−9000M−1 cm−1). OMVs samples were normalized according to total protein
concentrations, as quantified with the Pierce® BCA Protein Assay Kit (Thermo
Scientific). Uncropped images of the western blot are provided in the Source
Data file.
Cell fractionation and proteolysis experiments. E. coli cells were grown at 37 °C
until OD of 0.5, induced with 20 µM of IPTG for expression of VIM-2 or SPM-1
and growth continued for two hours. Cells were fractioned into periplasm and
spheroplasts by the EDTA-Lyzosime method as previously reported17. Briefly, E.
coli cultures were pelleted and cells were washed once with 20 mM Tris, 150 mM
NaCl, pH 8.0. The washed cells were resuspended in 20 mM Tris, 0.1 mM EDTA,
20% w per v sucrose, 1 mg ml−1 lysozyme (from chicken egg white, Sigma-Aldrich,
protein ≥ 90%), 0.5 mM PMSF, pH 8 (resuspension volume was normalized
according to the formula V= 100 μL × OD600 × Vc, where Vc is the starting volume
of culture sample), incubated with gentle agitation at 4 °C for 30 min, and finally
pelleted, with the periplasmic extract in the supernatant. A fraction of spheroplasts
were resuspended in 20 mM Tris, 150 NaCl, pH 8.0, lysed by sonication and
separated into soluble and insoluble fractions by centrifugation at 12,000 × g for
20 min at 4 °C. The remaining fraction of spheroplasts was resuspended in 20 mM
Tris, 10 mM CaCl2, pH 8.0 and treated with 50 µg ml–1 Proteinase K for 30 min
at 0 °C.
MIC determinations. Imipenem (IMI), ceftazidime (CAZ), cefepime (CFP), and
piperacillin (PIP) MIC determinations were performed in LB medium using the
agar macrodilution method according to CLSI guidelines71. In all cases, blaMBL
expression was induced with 10 μM IPTG.
Purification of OMVs. OMVs were purified from early stationary phase cultures of
E. coli, P. aeruginosa, and A. baumannii. Briefly, 250 ml of LB medium was
inoculated with 3 ml of saturated E. coli, P. aeruginosa or A. baumannii pMBLe-bla
culture, grown at 37 °C up to OD600 of 0.4, induced with 20 μM IPTG, and growth
continued overnight with agitation for the case of E. coli strains. In the case of P.
aeruginosa and A. baumannii strains, after IPTG addition, the growth was con-
tinued for 4 h at 37 °C17. The cells were harvested and the supernatant filtered
through a 0.45-μm membrane (Millipore). Ammonium sulfate was added to the
filtrate at a concentration of 55% w per v, followed by overnight incubation with
stirring at 4 °C. Precipitated material was separated by centrifugation at 12,800 x g
for 10 min, resuspended in 10 mM HEPES, 200 mM NaCl, pH 7.4, and dialyzed
overnight against > 100 volumes of the same buffer. Next, the samples were filtered
through a 0.45-μm membrane, layered over an equal volume of 50 % w per v
sucrose solution and ultracentrifuged at 150,000 × g for 1 h and 4 °C17. Pellets,
containing OMVs, were washed once with 10 mM HEPES, 200 mM NaCl, pH 7.4,
and stored at –80 °C until use. OMVs were quantified by total protein dosage with
the Pierce® BCA Protein Assay Kit (Thermo Scientific). These quantifications were
comparative for each bacterium given that the levels of MBLs in vesicles were
insignificant with respect to total protein amounts.
Quality of vesicle preps was assessed by negative staining transmission electron
microscopy, as described elsewhere20. Briefly, vesicles were fixed in 4%
glutaraldehyde in 10 mM HEPES, 200 mM NaCl, pH 7.4 for 30 min at room
temperature, stained with 2% uranyl acetate and visualized in a Zeiss EM 109T
Transmission Electron Microscope. Finally, the absence of cellular contaminants
due to cell lysis during culture growth or cell manipulation was verified by
immunodetection of cytoplasmic GroEL in OMV preps. GroEL antibodies were
kindly provided by Dr. Alejandro Viale (IBR-CONICET, Argentina).
Growth curves. Effects of MBLs expression on bacterial growth were obtained by
measuring cell density at OD600every 60 min in a BioTek Synergy two multimode
microplate reader for 15 h at 37 °C. All bacterial strains were grown in LB broth,
supplemented with gentamicin, at 37 °C and 200 rpm. Overnight cultures were
then diluted 1:100 in LB and applied in duplicate into a sterile 96-well microplate
(Greiner Bio-one) with gentamicin at 20 μg ml−1 and either with or without
addition of different concentrations of IPTG, as indicated. For evaluating the role
of carbapenemase activity on fitness cost, the growth curves were realized in the
absence and presence of an enzymatic activity inhibitor. For this, a bisthiazolidine
(L-CS319) was used at a concentration that ensured the complete inhibition of
MBLs36. All the data represent an average of at least three independent
experiments.
Bacterial viability by spot plating assay. To estimate the ability of bacterial cells
to survive and form a colony according to IPTG concentration, overnight cultures
were serially diluted and 10 µl aliquots spotted onto LB agar containing gentamicin
at 20 μg ml−1 and different concentrations of IPTG or no IPTG, as indicated.
Colonies were allowed to develop for 24 h at 37 °C before photographical
recording.
Multiple sequence alignment and phylogenetic trees. Signal peptide sequences
were aligned with the homology extention (PSI-Coffee) multiple sequence align-
ment tool available at http://www.tcoffee.org/. Phylogenetic trees were constructed
(LG substitution model and 100 bootstraps) using the maximum likelihood algo-
rithm PhyML (http://www.phylogeny.fr), and unrooted trees were drawn with
DrawTree from the Phylip package.
Preparation of peptidoglycan. Peptidoglycan was prepared, as previously
described72 from cultures of E. coli grown in LB medium at 37 °C with aeration.
Cells were grown overnight in LB medium with the appropriate antibiotic and then
cultured 1:100 into 300 ml of LB medium up to OD600 of 0.4, induced with 20 μM
IPTG, and growth continued for several hours until an OD600 of 1.5 was reached.
The cells were then incubated on ice until the temperature of the culture was 4 °C.
Samples were centrifuged at 10,000 × g for 10 min at 4 °C, resuspended in 3 ml of
distilled H2O, and slowly mixed drop by drop with an equal volume of 6% (wt/vol)
boiling SDS with vigorous stirring until the mixture was homogeneous. The cells
were boiled for 5 min, transferred into 10-ml glass tubes, and heated at 90 °C
for 24 h in a Baxter heat block. Sacculi were concentrated by centrifugation at
65,000 rpm for 15 min at 20 °C in an ultracentrifuge (Beckman-Optima TLX with a
TLA110 rotor). The pellet was washed with water until no SDS was detected,
according to the method of Hayashi73. The last pellet from the washing procedure
was suspended in 1 ml of 10 mM Tris-HCl (pH 7.2) and digested first with
100 μg ml−1 α-amylase (EC 3.2.1.1; Sigma-Aldrich, St. Louis, MO) for 1 h at 37 °C
and then with 100 μg ml−1 preactivated pronase E (EC 3.4.24.4; Merck, Darmstadt,
Germany) at 60 °C for 90 min. The enzymes were inactivated by boiling for 20 min
in 1% (final concentration) SDS. The cell walls were collected by centrifugation as
described above and washed three times with water. Peptidoglycan was stored in
water at 4 °C.
Preparation and separation of muropeptides. Peptidoglycan was digested in
50 mM phosphate buffer (pH 4.9) with Cellosyl (Hoechst AG, Frankfurt, Ger-
many), at a 100 μg ml−1 final concentration, at 37 °C overnight. The enzyme was
inactivated by boiling the sample for 2 min in a water bath and centrifugation
(Eppendorf centrifuge at maximum speed for 10 min) to remove insoluble debris.
The supernatant was mixed with a 1/3 volume of 0.5 M sodium borate buffer
(pH 9.0) and reduced with excess sodium borohydride (NaBH4) for 30 min at room
temperature. The pH was tested with pH indicator strips (Acilit; Merck) and
adjusted to pH 3 with orthophosphoric acid. All samples were filtered (Millex-GV
filters with a 0.22 μm pore size and a 2.5 mm diameter; Millipore, Cork, Ireland)
and stored at −20 °C. Separation of the reduced muropeptides was performed
essentially as described previously by Glauner et al.74,75. Muropeptides were ana-
lyzed by using a binary-pump Waters high-performance liquid chromatography
(HPLC) system (Waters Corporation) fitted with a reverse-phase RP18 Aeris
peptide column (250 by 4.6 mm with a 3.6-μm particle size; Phenomenex, USA)
and a dual-wavelength absorbance detector (Waters UV-1570 spectrophotometer).
The eluted muropeptides were monitored by measuring the absorbance at 204 nm.
When required, the individual peaks were collected, vacuum dried, and stored
at −20 °C.
Quantification of muropeptides. Individual muropeptides were quantified from
their integrated areas (Waters Breeze) by using samples of known concentrations as
standards. Concentrations of the standard muropeptides were determined as
described previously by Work76. The average PG chain length was calculated by
dividing the molar amount of anhydro-muropeptide (chain termini) by the total
molar amount of muropeptides in muramidase-digested PG, and the degree of
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cross-linking was calculated by calculating the molar ratio of dimers and trimers to
total muropeptide, as described previously by Glauner et al.74,75. In each experi-
ment, muropeptides were quantified from two biological replicates, and the average
molar ratio (mol%) values are presented (see Supplementary Table 2). Experi-
mental variation resulted in changes for each muropeptide measurement of ≤ 5%.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data supporting the findings of this study are available within the article and
its Supplementary Information files. Source data for figures are provided as a Source
Data file.
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